A Comparative Study Of Iodine I 131 Tositumomab Therapeutic Regimen Versus Ibritumomab Tiuxetan Therapeutic Regimen

This study has been withdrawn prior to recruitment.

Study NCT00319332 Information provided by GlaxoSmithKline

First Received: April 26, 2006 Last Updated: January 24, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been withdrawn prior to recruitment.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given